通过分子动力学模拟与机器学习相结合,研究SHP2的 conformational transition和其高强度体抑制剂的结构性表征
Baerlike Wujieti1, Mingtian Hao1, Erxia Liu1
1School of Chemical Sciences, University of Chinese Academy of Sciences, No. 19A, Yuquan Road, Beijing 100049, China.
Molecules (Basel, Switzerland)
|January 11, 2025
概括
这项研究揭示了SHP2 (src-homology 2域含酸酶2) 全抑制剂的关键结构特征. 对模拟的机器学习分析为SHP2提供了洞察力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- SHP2 (src-homology 2域含酸酶2) 是细胞信号传递的一个关键调节剂.
- 异常的SHP2活性驱动瘤生长和免疫抑制,使其成为癌症治疗目标.
- 阿洛斯特抑制剂为向SHP2提供了一个有希望的策略,克服了催化部位抑制剂的局限性.
研究的目的:
- 通过分子动力学模拟来研究SHP2全抑制剂的相互作用模型.
- 探索SHP2激活的自由能量场景,并了解其结构变化.
- 应用可解释的机器学习来分析模拟数据和识别关键结构驱动因素.
主要方法:
- 分子动力学 (MD) 模拟用于模拟抑制剂-SHP2相互作用.
- 超动力学模拟用于绘制SHP2激活的自由能量景观.
- 极端梯度增强 (XGBoost) 与沙普利增量解释 (SHAP) 用于分析模拟轨迹.
主要成果:
- 确定了控制SHP2形态动态的关键结构特征.
- 阐明了SHP2激活和全抑制的机制.
- 突出了设计强效SHP2全抑制剂的关键相互作用.
结论:
- 对SHP2全抑制剂机制的高级理解.
- 为开发新的SHP2向癌症疗法提供了关键的见解.
- 建议在SHP2向治疗中解决耐药性的策略.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
350
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
494
相关概念视频
Cooperative Allosteric Transitions
2.3K
2.3K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Allosteric Regulation
57.6K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.6K
